Page last updated: 2024-09-02

fingolimod hydrochloride and Hyperglycemia

fingolimod hydrochloride has been researched along with Hyperglycemia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akin, M; Arndt, T; Hedrich, HJ; Jörns, A; Lenzen, S; Terbish, T; Wedekind, D; Zu Vilsendorf, AM1
Goda, N; Kataoka, N; Makino, H; Nishishita, S; Omori, K; Sarai, K; Sasaki, M; Shikata, K; Shikata, Y; Wada, J; Watanabe, N1
Choi, J; Ma, ZA; Zhao, C; Zhao, Z1

Other Studies

3 other study(ies) available for fingolimod hydrochloride and Hyperglycemia

ArticleYear
Anti-TCR therapy combined with fingolimod for reversal of diabetic hyperglycemia by β cell regeneration in the LEW.1AR1-iddm rat model of type 1 diabetes.
    Journal of molecular medicine (Berlin, Germany), 2014, Volume: 92, Issue:7

    Topics: Animals; Antibodies; Cell Proliferation; Cytokines; Diabetes Mellitus, Type 1; Disease Models, Animal; Drug Therapy, Combination; Fingolimod Hydrochloride; Hyperglycemia; Immunosuppressive Agents; Insulin-Secreting Cells; Lymph Nodes; Macrophages; Microscopy, Electron, Transmission; Propylene Glycols; Rats; Receptors, Antigen, T-Cell; Sphingosine; T-Lymphocytes

2014
Endothelial barrier protection by FTY720 under hyperglycemic condition: involvement of focal adhesion kinase, small GTPases, and adherens junction proteins.
    American journal of physiology. Cell physiology, 2009, Volume: 297, Issue:4

    Topics: Actins; Adherens Junctions; Cadherins; Cell Adhesion Molecules; Cells, Cultured; Electric Impedance; Endothelial Cells; Endothelium, Vascular; Fingolimod Hydrochloride; Focal Adhesion Protein-Tyrosine Kinases; Humans; Hyperglycemia; Immunosuppressive Agents; Lysophospholipids; Microvessels; Monomeric GTP-Binding Proteins; Phosphorylation; Propylene Glycols; rac GTP-Binding Proteins; Receptors, Lysosphingolipid; rho GTP-Binding Proteins; Sphingosine

2009
FTY720 normalizes hyperglycemia by stimulating β-cell in vivo regeneration in db/db mice through regulation of cyclin D3 and p57(KIP2).
    The Journal of biological chemistry, 2012, Feb-17, Volume: 287, Issue:8

    Topics: Administration, Oral; Animals; Cell Count; Cell Proliferation; Cell Survival; Cyclin D3; Cyclin-Dependent Kinase Inhibitor p57; Down-Regulation; Female; Fingolimod Hydrochloride; Hyperglycemia; Insulin-Secreting Cells; Mice; Phosphatidylinositol 3-Kinases; Propylene Glycols; Receptors, Lysosphingolipid; Signal Transduction; Sphingosine; Up-Regulation

2012